Dr. Tran has participated in all phases of patent litigation, including pre-suit investigations, fact and expert discovery, and trial in federal courts. She currently focuses her practice on biotechnology and pharmaceuticals. Dr. Tran has also been involved in preparing petitions for inter partes review to the USPTO.
Dr. Tran is a member of the American Intellectual Property Law Association (AIPLA) and the Asian American Bar Association of NY (AABANY).
Dr. Tran's graduate research in organic chemistry focused on developing a stereoelectronic model to explain the stereoselective addition of nucleophiles to oxocarbenium ions to provide substituted tetrahydrofurans. The tetrahydrofuran motif is common in natural products, as well as in synthetic compounds for therapeutic use.
Prior to joining Goodwin, Dr. Tran worked in medicinal chemistry research at Johnson & Johnson Pharmaceutical Research & Development (2005-2008). Her synthetic chemistry background was applied to the discovery of new chemical entities for therapeutic use.
Dr. Tran is a member of the Association for Women in Science and the American Chemical Society.